We analyze your existing API data, identify crystallization risks, and define key objectives (polymorph, PSD, purity, yield)
Enabling Preclinical Formulation Services
Take your drug from the lab to clinical trials by overcoming solubility challenges.
At Solitek, we transform poorly soluble active pharmaceutical ingredients (APIs) into effective, stable formulations to ensure the success of your toxicology, efficacy, and pharmacokinetic studies.
Maximum Solubility
We have achieved concentrations up to more than 800 mg/mL for complex molecules through custom-tailored formulations.
API Savings
We used optimized protocols to obtain maximum results while consuming the minimum amount of material (milligrams).
Biorelevant Simulation
We evaluate drug response in simulated gastric and intestinal fluids to predict behavior in animal and human studies.
+ 40 Years of Solid State Science
Over 40 years dedicated to solid-state science, its development, and optimization.
Formulation Development Services
Insufficient Absorption in Preclinical Trials:
Poor solubility prevents the drug from entering the bloodstream in the concentration needed to achieve a therapeutic effect.
Variable Preclinical Data:
Drug precipitation in the intestine causes absorption results to vary too widely between subjects, undermining the reliability of the study.
Waste of Promising Drug Candidates:
Formulating without a prior strategy quickly depletes valuable active pharmaceutical ingredient before valid results can be obtained.
Regulatory Roadblock:
Lacking a tolerable formulation stalls program progress and delays the submission of dossiers to regulatory bodies.
Devaluation of the Candidate:
A poor absorption profile undermines buyer or licensee confidence, devaluing the candidate's commercial potential.
Our Enabling Formulation Services
1. Rapid Excipient Screening
We rapidly screen different approved cosolvents, lipids, and additives at microscale to find the perfect blend that dissolves your drug without causing toxicity.
2. Amorphous Solid Dispersion (ASD) Development
We stabilize your drug in its high-energy amorphous form using polymer matrices, preventing recrystallization back to the more stable — but less soluble — crystalline form, and unlocking superior dissolution.
3. Lipid-Based Formulations and Nanoemulsions
We design self-emulsifying, lipid-based systems that keep poorly soluble drugs fully dissolved and ready for absorption throughout the entire intestine.
4. Biorelevant Dissolution Testing
We test how the drug dissolves and behaves in simulated gastric and intestinal fluids under different conditions, to ensure its stability before advancing development.
Strategic Benefits of Partnering with Solitek for Early Formulations
- We develop enabling formulations that dramatically boost the solubility of complex molecules, allowing you to reach the doses required for demanding toxicology studies.
- We carefully select the ideal excipients to ensure safe, stable, reproducible dissolution profiles, eliminating variability in PK studies.
- We save API during the preclinical phase by optimizing microscale formulation protocols to consume the minimum amount necessary.
- We de-risk and accelerate development with high-confidence predictive testing, evaluating the drug in vitro using biorelevant media to anticipate in vivo behavior before the first animal study.
- We know how to select combinations of tolerable excipients that are compatible with preclinical routes of administration, avoiding toxic side effects attributable to the vehicle or formulation.
- We establish the technical formulation foundation that facilitates subsequent scale-up to solid or liquid clinical dosage forms, reducing the failures during the critical CMC phase.
- We reduce costs and accelerate preclinical development timelines through our proprietary rapid screening protocols and predictive modeling.
- We deliver detailed analytical reports documenting formulation solubility, stability, and behavior, essential for critical decision-making.
Enabling Formulation & Bioavailability Enhancement
If You're a Biotech:
We optimize microscale protocols, maximizing your API material while meeting the highest safety and toxicity standards.
If You're a Generics Company:
We design advanced, non-infringing formulations to overcome patent barriers, ensure success in bioequivalence studies, and accelerate your time to market with reliable protocols and formulations.
If You're a Pharma Company:
We accelerate your clinical programs with advanced, scalable formulations that resolve regulatory challenges, ensuring a frictionless transition to animal or human trials.
Testimonials from Pharmaceutical Companies That Have Already Put Their Trust in Solitek
Posted on Google
Neil SimTrustindex verifies that the original source of the review is Google.
At HFR, we have collaborated with Solitek across numerous projects for a number of years. Across all projects that we have collaborated on, I have felt that Solitek really work to fully understand the project from the outset. Victor, Steve and all of the team provide expert knowledge across the solid state landscape and combine a methodical approach with scientific rigour. Their communication and reporting is thorough and clearly presented, providing further value when working on more challenging and complex landscapes.Posted on Google
Anthony DebonoTrustindex verifies that the original source of the review is Google.
I have collaborated directly with Solitek on a number of projects. I highly recommend the team. They combine deep technical expertise and experimental know-how, with an efficient and collaborative customer service. Thanks to their decades of experience in the field they are able to give solid advice on development approaches and are proactive and transparent during project execution.Posted on Google
Josep CastellsTrustindex verifies that the original source of the review is Google.
La experiencia con Solitek durante el desarrollo de una molécula activa farmacéuticamente fue muy positiva por su gran profesionalidad y la capacidad de superar los retoques técnicos.Posted on Google
Adria Espinas TorresTrustindex verifies that the original source of the review is Google.
Great experience working with Solitek from Farmhispania Group on solid-state projects. We collaborated in the development of robust and scalable API crystallization processes and solid form selection and characterization, and they always bring clear, practical solutions. Working with Steve, Víctor, and the rest of the team has been very smooth, with close and easy communication throughout. They are agile, adapt well to project needs, and are strongly results-oriented. Strongly recommended!Posted on Google
DavidTrustindex verifies that the original source of the review is Google.
AKL Therapeutics had approached Solitek regarding an unusual and difficult issue associated with a liquid eutectic formulation. Solitek devised a clear and systematic plan of investigations to solve the outstanding problems and were well equipped to conduct the necessary specialist studies in this area. The staff have very good practical knowledge and experience in the area of pharmaceutical formulation development. The investigations Solitek conducted proved to be fully enlightening as to and understanding of key issues involved in the development of a suitable formulation for the concerned molecules. The standard of reporting was excellent with regular scheduled updates that were well communicated by the Solitek team. We would certainly recommend Solitek as a competent and capable partner in the area of pharmaceutical formulation development. John McCrerie for AKL TherapeuticsPosted on Google
Ernesto Durán LópezTrustindex verifies that the original source of the review is Google.
Over the past few years, we have carried out several collaborations with Solitek to address different aspects related to the solid‑state development of pharmaceutical active ingredients. These projects have included salt‑screening studies to modulate API solubility, the exploration of new polymorphic forms and co‑crystals to help overcome IP barriers, and the optimization of process parameters to enhance the robustness of crystallizations at industrial scale. Throughout all these collaborations, the Solitek team has consistently demonstrated strong technical expertise, provided high‑value scientific input, met every agreed timeline, and delivered reports of outstanding quality. Without a doubt, having them by our side when complex challenges arise makes a real difference.Posted on Google
DBS ChenTrustindex verifies that the original source of the review is Google.
With over 20 yrs of outsourcing experience, I have to say Solitek is efficient, comprehensive, and budget-friendly. Their expertise gives me peace of mind when they handle my projects.Posted on Google
Marta MonjoTrustindex verifies that the original source of the review is Google.
Solitek nos ha ayudado muchísimo en la optimización y el escalado de nuestro proceso. Han demostrado un gran conocimiento técnico y una excelente capacidad para encontrar soluciones prácticas a los retos que han ido surgiendo durante el proyecto. Los estudios de familiarización realizados posteriormente en planta kilo-lab fueron todo un éxito y nos aportaron información muy útil para seguir avanzando. Además, durante todo el proceso de industrialización han seguido brindándonos apoyo y asesoramiento ante cualquier consulta o necesidad que ha surgido, demostrando un gran compromiso con el éxito del proyecto. Ha sido un placer trabajar con un equipo tan profesional, cercano y comprometido. Muchas gracias!Posted on Google
I MaikelTrustindex verifies that the original source of the review is Google.
Nuestras colaboraciones con Solitek han sido muy satisfactorias. Su profundo conocimiento del estado sólido, y de los procesos de optimización y escalado han rendido procesos sólidos, fiables, bien documentados y fáciles de transferir. Un placer trabajar con ellos.Posted on Google
Jacques Alain BauerTrustindex verifies that the original source of the review is Google.
The experience with Solitek Pharma projects were perfect, with real-time communication, very flexible collaboration and excellent reporting.
Company specializing in enabling formulation services
Solitek Pharma was founded to reduce risk and prevent costly failures in small molecule drug development, drawing on over 50 years of accumulated experience in the pharmaceutical industry, including more than 40 years focused specifically on solid-state science.
Our expertise was built at internationally recognized pharmaceutical companies such as GSK, Johnson Matthey, and Almac, Spanish companies such as Esteve and Medichem, and specialized solid-state teams such as Pharmorphix and Enantia.
We have participated in more than 1,000 drug development programs, giving us the practical perspective needed to approach each project with a clear sense of what truly needs to be accomplished and decided at every stage.
Our current company, Solitek Pharma, was founded in 2021 and is based at the Barcelona Science Park (Parc Científic de Barcelona), a hub for operations and specialized talent in our sector.
We are an agile team of experts who work closely with our clients, integrating as an extension of their development teams. We focus on what’s needed here and now, helping projects advance with lower risk and greater value for future partners.
Working Together and Strategic Partners
Our 3-Step Work Process
We execute the work plan at our facilities in the Barcelona Science Park, using advanced characterization and screening tools to reduce risk and optimize every phase of the process.
We deliver a detailed, actionable technical report, ready for use in regulatory audits or direct transfer to your CDMO.
Frequently Asked Questions About Enabling Formulations Services
1. What is an enabling formulation in the early stages of drug development?
An enabling formulation is a technical vehicle designed to temporarily solubilize and stabilize molecules with poor solubility (BCS Class II/IV). Its purpose is to ensure adequate in vivo exposure during PK, efficacy, and preclinical toxicology studies.
2. How does Solitek minimize API consumption during formulation evaluation?
At Solitek Pharma, we use microscale screening protocols that allow us to evaluate dozens of excipient combinations while consuming only fractions of a gram of API — making this approach highly cost-effective for early-stage development programs.
3. What formulation technologies does Solitek offer?
We specialize in oral and injectable solutions, as well as stabilized oral suspensions, designed from a deep foundation in solid-state science and crystallization behavior.
This approach allows us to select the optimal solid form and formulation system from the outset — avoiding the trial-and-error excipient screening typical of generalist providers. Other technologies, such as ASD or HME, can be used to address specific challenges.
4. How is formulation performance validated before PK or Tox studies?
We evaluate in vitro dissolution, solubility and precipitation behavior using physiological, biorelevant media (FaSSIF/FeSSIF) that simulate the human or animal species gastrointestinal environments, providing strong predictive insight ahead of in vivo studies.
Do You Have a Promising Drug That's Insoluble?
Don’t let solubility issues stand between your molecule and clinical trials.
Partner with Solitek Pharma’s solid-state and enabling formulation experts to maximize in vivo bioavailability.